Your browser doesn't support javascript.
loading
MIR137 polygenic risk for schizophrenia and ephrin-regulated pathway: Role in lateral ventricles and corpus callosum volume.
Blokland, G A M; Maleki, N; Jovicich, J; Mesholam-Gately, R I; DeLisi, L E; Turner, J A; Shenton, M E; Voineskos, A N; Kahn, R S; Roffman, J L; Holt, D J; Ehrlich, S; Kikinis, Z; Dazzan, P; Murray, R M; Lee, J; Sim, K; Lam, M; de Zwarte, S M C; Walton, E; Kelly, S; Picchioni, M M; Bramon, E; Makris, N; David, A S; Mondelli, V; Reinders, A A T S; Oykhman, E; Morris, D W; Gill, M; Corvin, A P; Cahn, W; Ho, N; Liu, J; Gollub, R L; Manoach, D S; Calhoun, V D; Sponheim, S R; Buka, S L; Cherkerzian, S; Thermenos, H W; Dickie, E W; Ciufolini, S; Reis Marques, T; Crossley, N A; Purcell, S M; Smoller, J W; van Haren, N E M; Toulopoulou, T; Donohoe, G.
Afiliação
  • Blokland GAM; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Faculty of Health, Medicine, and Life Sciences, Maastricht University, Netherlands.
  • Maleki N; Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United States.
  • Jovicich J; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
  • Mesholam-Gately RI; Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
  • DeLisi LE; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, United States.
  • Turner JA; MGH/HST Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States.
  • Shenton ME; Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
  • Voineskos AN; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
  • Kahn RS; Center for Mind/Brain Sciences (CIMeC), University of Trento, Trento, Italy.
  • Roffman JL; Massachusetts Mental Health Center Public Psychiatry Division, Beth Israel Deaconess Medical Center, Boston, MA, United States.
  • Holt DJ; Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
  • Ehrlich S; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
  • Kikinis Z; Department of Psychiatry, Cambridge Health Alliance, Cambridge, MA, United States.
  • Dazzan P; Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
  • Murray RM; Department of Psychiatry and Behavioral Health, The Ohio State University, Columbus, OH, United States.
  • Lee J; Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, United States.
  • Sim K; Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
  • Lam M; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
  • de Zwarte SMC; Department of Psychiatry, Veterans Affairs Boston Healthcare System, Brockton, MA, United States.
  • Walton E; Kimel Family Translational Imaging Genetics Laboratory, Department of Psychiatry, Research Imaging Centre, Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Kelly S; Department of Psychiatry and Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Picchioni MM; Brain Centre Rudolf Magnus, Department of Psychiatry, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Bramon E; Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
  • Makris N; MGH/HST Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States.
  • David AS; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
  • Mondelli V; Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
  • Reinders AATS; MGH/HST Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States.
  • Oykhman E; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
  • Morris DW; Division of Psychological & Social Medicine and Developmental Neurosciences, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Gill M; Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, United States.
  • Corvin AP; Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
  • Cahn W; Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
  • Ho N; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, United Kingdom.
  • Liu J; Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
  • Gollub RL; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, United Kingdom.
  • Manoach DS; Institute of Mental Health, Woodbridge Hospital, Singapore.
  • Calhoun VD; Institute of Mental Health, Woodbridge Hospital, Singapore.
  • Sponheim SR; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, United States.
  • Buka SL; Analytical & Translational Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United States.
  • Cherkerzian S; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
  • Thermenos HW; Institute of Mental Health, Woodbridge Hospital, Singapore.
  • Dickie EW; Brain Centre Rudolf Magnus, Department of Psychiatry, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Ciufolini S; Department of Psychology, University of Bath, Bath, United Kingdom.
  • Reis Marques T; Neuropsychiatric Genetics Research Group, Department of Psychiatry, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland.
  • Crossley NA; Laboratory of NeuroImaging, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Purcell SM; Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
  • Smoller JW; Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
  • van Haren NEM; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, United Kingdom.
  • Toulopoulou T; Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
  • Donohoe G; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, London, United Kingdom.
Int J Clin Health Psychol ; 24(2): 100458, 2024.
Article em En | MEDLINE | ID: mdl-38623146
ABSTRACT
Background/Objective. Enlarged lateral ventricle (LV) volume and decreased volume in the corpus callosum (CC) are hallmarks of schizophrenia (SZ). We previously showed an inverse correlation between LV and CC volumes in SZ, with global functioning decreasing with increased LV volume. This study investigates the relationship between LV volume, CC abnormalities, and the microRNA MIR137 and its regulated genes in SZ, because of MIR137's essential role in neurodevelopment. Methods. Participants were 1224 SZ probands and 1466 unaffected controls from the GENUS Consortium. Brain MRI scans, genotype, and clinical data were harmonized across cohorts and employed in the analyses. Results. Increased LV volumes and decreased CC central, mid-anterior, and mid-posterior volumes were observed in SZ probands. The MIR137-regulated ephrin pathway was significantly associated with CCLV ratio, explaining a significant proportion (3.42 %) of CCLV variance, and more than for LV and CC separately. Other pathways explained variance in either CC or LV, but not both. CCLV ratio was also positively correlated with Global Assessment of Functioning, supporting previous subsample findings. SNP-based heritability estimates were higher for CC centralLV ratio (0.79) compared to CC or LV separately. Discussion. Our results indicate that the CCLV ratio is highly heritable, influenced in part by variation in the MIR137-regulated ephrin pathway. Findings suggest that the CCLV ratio may be a risk indicator in SZ that correlates with global functioning.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Clin Health Psychol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Clin Health Psychol Ano de publicação: 2024 Tipo de documento: Article